Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE38.9900
- TODAY'S CHANGE (%)1.5800 (4.2235%)
- Bid / Lots37.7700/ 7
- Ask / Lots50.0000/ 1
- Open / Previous Close37.5100 / 37.4100
- Day Range
- 52 Week Range
- Volume498,273
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 1086 | 37.51 |
| 09:34 ET | 100 | 37.34 |
| 09:36 ET | 200 | 37.46 |
| 09:50 ET | 200 | 37.36 |
| 09:57 ET | 200 | 37.47 |
| 10:01 ET | 100 | 37.52 |
| 10:08 ET | 100 | 37.585 |
| 10:17 ET | 600 | 37.73 |
| 10:24 ET | 800 | 37.745 |
| 10:26 ET | 1120 | 37.7 |
| 10:28 ET | 600 | 37.69 |
| 10:30 ET | 1217 | 37.575 |
| 10:32 ET | 416 | 37.575 |
| 10:33 ET | 500 | 37.575 |
| 10:35 ET | 300 | 37.575 |
| 10:37 ET | 200 | 37.575 |
| 10:39 ET | 500 | 37.46 |
| 10:46 ET | 1899 | 37.575 |
| 10:50 ET | 100 | 37.615 |
| 10:51 ET | 815 | 37.68 |
| 10:53 ET | 600 | 37.695 |
| 10:55 ET | 100 | 37.675 |
| 10:57 ET | 700 | 37.67 |
| 11:00 ET | 400 | 37.71 |
| 11:02 ET | 2201 | 37.97 |
| 11:06 ET | 205 | 37.91 |
| 11:08 ET | 304 | 37.87 |
| 11:11 ET | 500 | 37.95 |
| 11:13 ET | 100 | 37.88 |
| 11:15 ET | 400 | 37.94 |
| 11:18 ET | 300 | 37.875 |
| 11:20 ET | 143 | 37.93 |
| 11:22 ET | 607 | 37.92 |
| 11:24 ET | 412 | 37.875 |
| 11:26 ET | 200 | 37.87 |
| 11:29 ET | 317 | 37.91 |
| 11:31 ET | 300 | 37.92 |
| 11:33 ET | 2300 | 37.925 |
| 11:36 ET | 404 | 37.885 |
| 11:38 ET | 1467 | 37.91 |
| 11:40 ET | 700 | 37.97 |
| 11:42 ET | 504 | 37.915 |
| 11:44 ET | 500 | 37.91 |
| 11:45 ET | 1749 | 37.905 |
| 11:47 ET | 447 | 37.9 |
| 11:49 ET | 9340 | 38 |
| 11:51 ET | 804 | 37.975 |
| 11:54 ET | 1295 | 38 |
| 11:56 ET | 100 | 38.01 |
| 11:58 ET | 524 | 38 |
| 12:00 ET | 276 | 38.005 |
| 12:02 ET | 689 | 38.12 |
| 12:03 ET | 654 | 38.18 |
| 12:05 ET | 200 | 38.17 |
| 12:07 ET | 100 | 38.18 |
| 12:09 ET | 200 | 38.2 |
| 12:12 ET | 100 | 38.2 |
| 12:14 ET | 300 | 38.2 |
| 12:16 ET | 202 | 38.14 |
| 12:18 ET | 6100 | 38.07 |
| 12:20 ET | 300 | 38.06 |
| 12:21 ET | 3404 | 38.23 |
| 12:23 ET | 1000 | 38.31 |
| 12:25 ET | 1022 | 38.275 |
| 12:27 ET | 343 | 38.32 |
| 12:30 ET | 100 | 38.36 |
| 12:32 ET | 585 | 38.43 |
| 12:34 ET | 200 | 38.42 |
| 12:36 ET | 303 | 38.42 |
| 12:38 ET | 7387 | 38.45 |
| 12:39 ET | 4517 | 38.47 |
| 12:41 ET | 600 | 38.46 |
| 12:43 ET | 200 | 38.48 |
| 12:45 ET | 600 | 38.465 |
| 12:48 ET | 5223 | 38.62 |
| 12:50 ET | 100 | 38.64 |
| 12:52 ET | 430 | 38.575 |
| 12:54 ET | 903 | 38.49 |
| 12:56 ET | 1059 | 38.59 |
| 12:57 ET | 200 | 38.7 |
| 12:59 ET | 330 | 38.69 |
| 01:01 ET | 100 | 38.68 |
| 01:03 ET | 5878 | 38.67 |
| 01:06 ET | 671 | 38.62 |
| 01:08 ET | 100 | 38.64 |
| 01:10 ET | 820 | 38.59 |
| 01:12 ET | 234 | 38.64 |
| 01:15 ET | 2273 | 38.69 |
| 01:17 ET | 660 | 38.63 |
| 01:19 ET | 2481 | 38.66 |
| 01:21 ET | 2199 | 38.68 |
| 01:24 ET | 3863 | 38.76 |
| 01:26 ET | 300 | 38.73 |
| 01:28 ET | 1000 | 38.72 |
| 01:30 ET | 4308 | 38.73 |
| 01:32 ET | 400 | 38.705 |
| 01:33 ET | 600 | 38.71 |
| 01:35 ET | 3444 | 38.6725 |
| 01:37 ET | 1637 | 38.51 |
| 01:39 ET | 400 | 38.49 |
| 01:42 ET | 700 | 38.53 |
| 01:44 ET | 504 | 38.54 |
| 01:46 ET | 500 | 38.72 |
| 01:48 ET | 948 | 38.82 |
| 01:50 ET | 800 | 38.8 |
| 01:51 ET | 3752 | 38.75 |
| 01:53 ET | 100 | 38.73 |
| 01:55 ET | 622 | 38.72 |
| 01:57 ET | 100 | 38.77 |
| 02:00 ET | 500 | 38.78 |
| 02:02 ET | 510 | 38.785 |
| 02:04 ET | 2244 | 38.8 |
| 02:06 ET | 100 | 38.78 |
| 02:08 ET | 3897 | 38.8 |
| 02:09 ET | 300 | 38.8 |
| 02:11 ET | 100 | 38.8 |
| 02:13 ET | 931 | 38.91 |
| 02:18 ET | 400 | 38.95 |
| 02:20 ET | 4617 | 38.915 |
| 02:24 ET | 100 | 38.87 |
| 02:26 ET | 100 | 38.88 |
| 02:27 ET | 700 | 38.94 |
| 02:29 ET | 3309 | 38.87 |
| 02:38 ET | 200 | 38.87 |
| 02:40 ET | 100 | 38.89 |
| 02:42 ET | 3511 | 38.85 |
| 02:44 ET | 1319 | 38.87 |
| 02:47 ET | 100 | 38.865 |
| 02:49 ET | 979 | 38.86 |
| 02:51 ET | 8011 | 38.75 |
| 02:54 ET | 608 | 38.73 |
| 02:56 ET | 400 | 38.735 |
| 02:58 ET | 1509 | 38.72 |
| 03:00 ET | 500 | 38.71 |
| 03:02 ET | 460 | 38.66 |
| 03:03 ET | 200 | 38.61 |
| 03:05 ET | 1745 | 38.52 |
| 03:07 ET | 500 | 38.55 |
| 03:09 ET | 300 | 38.57 |
| 03:12 ET | 2839 | 38.64 |
| 03:14 ET | 100 | 38.66 |
| 03:16 ET | 200 | 38.62 |
| 03:18 ET | 1535 | 38.63 |
| 03:20 ET | 300 | 38.66 |
| 03:21 ET | 375 | 38.66 |
| 03:23 ET | 300 | 38.66 |
| 03:25 ET | 2243 | 38.65 |
| 03:27 ET | 2409 | 38.63 |
| 03:30 ET | 600 | 38.615 |
| 03:32 ET | 900 | 38.565 |
| 03:34 ET | 400 | 38.57 |
| 03:36 ET | 700 | 38.56 |
| 03:38 ET | 2114 | 38.5423 |
| 03:39 ET | 2305 | 38.555 |
| 03:41 ET | 200 | 38.56 |
| 03:43 ET | 1312 | 38.47 |
| 03:45 ET | 2775 | 38.5255 |
| 03:48 ET | 1365 | 38.49 |
| 03:50 ET | 1519 | 38.45 |
| 03:52 ET | 3536 | 38.64 |
| 03:54 ET | 978 | 38.5975 |
| 03:56 ET | 7448 | 38.54 |
| 03:57 ET | 29339 | 38.97 |
| 03:59 ET | 38168 | 38.99 |
Jun 18, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 8:59AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:59AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 5, 2024
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.9B | -14.4x | --- |
Biohaven Ltd | 3.1B | -5.1x | --- |
MoonLake Immunotherapeutics | 2.8B | -58.6x | --- |
SpringWorks Therapeutics Inc | 2.8B | -7.3x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Geron Corp | 2.5B | -12.2x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
